Clinical Trials and Development Services
| Brecon Pharmaceuticals | ||
Customers regard Brecon as a valuable, reliable and trusted partner. |
Brecon Pharmaceuticals is a leading outsource services provider to the global pharmaceutical industry. |
Brecon has installed a tenth Romaco blister packer. |
From left to right: Brecon's business development manager for its analytical services unit, Jane Sanderson; Ken Caldicott, consultant; Sue Miles, director of clinical trials services; and Russell Thomson, QA and regulatory affairs director. |
Steve Kemp, business development director at Brecon Pharmaceuticals. |
|
| c-LEcta GmbH | ||
c-LEcta’s management team is looking forward to discussing the potentials of cooperation with you. |
c-LEcta runs 600 m² of top equipped lab space. |
c-LEcta is located in a biotechnology centre in Leipzig called Bio City. |
c-LEcta uses proprietary technologies with state of the art equipment. |
c-LEcta develops efficient enzyme production processes based on microbial fermentation. |
|
| CEPHA s.r.o. | ||
CEPHA's Headquarters are located in Pilsen, Czech Republic. |
The subjects are under full medical control at Phase I Clinic. |
Timing of blood sample collection is critical step in pharmacokinetic studies. |
High throughput in biological samples processing is a key to effective drug analysis. |
The latest analytical technology is applied for the determination of trace drug levels in complex matrices. |
|
| SydPath Central Laboratory | ||
SydPath's Central Laboratory Service was established in 1995, and has quickly established its reputation as a top class provider of central laboratory services within Australia. |
SydPath participates in both pharmaceutical- sponsored drug trials and grant-funded research as a local laboratory site for its St. Vincent's campus based researchers, as well as for locally based GPs. |
We will tailor our services to meet your specific needs, which may include the provision of pathology collection kits, investigator manuals and transport materials. |
| VIBevents | ||
The fifth annual Pharmacovigilance and Risk Management conference will be held 1-2 December 2009 in Brussels, Belgium. |
The conference will provide an opportunity for pharma and biotech professionals to come together to discuss how to develop a robust pharmacovigilance strategy in which there are no gaps. |
The conference is tailored to maximise the sharing of knowledge and expertise surrounding the important issues of pharmacovigilance and risk management. |
